Skip to main content English

Webseiten-Inhalte

COVID-19: Nicht alle PatientInnen entwickeln schützende Antikörper ... Perkmann, Doris Trapin, Martina Trella, Paul Ettel, Inna Tulaeva, Winfried F. Pickl, Rudolf Valenta. https://doi.org/10.1111/all.14523. LINK: https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14523. Share Whatsapp Facebook LinkedIn Xing Mail BlueSky Alle News... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2020/news-im-august-2020/covid-19-nicht-alle-patientinnen-entwickeln-schuetzende-antikoerper/
COVID-19: Nicht alle PatientInnen entwickeln schützende Antikörper ... Perkmann, Doris Trapin, Martina Trella, Paul Ettel, Inna Tulaeva, Winfried F. Pickl, Rudolf Valenta. https://doi.org/10.1111/all.14523. LINK: https://onlinelibrary.wiley.com/doi/abs/10.1111/all.14523. Share Whatsapp Facebook LinkedIn Xing Mail BlueSky Alle News... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2020/news-im-august-2020/covid-19-nicht-alle-patientinnen-entwickeln-schuetzende-antikoerper/medizin-wissenschaft/
COVID-19: not all patients develop protective antibodies ... COVID-19 do not always prevent virus receptor binding." Pia Gattinger, Kristina Borochova, Yulia Dorofeeva, Rainer Henning, Renata Kiss, Bernhard Kratzer, Bernhard Mühl, Thomas Perkmann, Doris Trapin, Martina Trella, Paul Ettel, Inna Tulaeva, Winfried F. Pickl, Rudolf Valenta. https://doi.org/10... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-august-2020/covid-19-not-all-patients-develop-protective-antibodies/medicine-science/
Detailsite | MedUni Vienna .... Christoph Zielinski). Ihre Forschungsergebnisse entstanden in enger Kooperation mit Univ. Prof. Dr. Winfried Pickl vom Institut für Immunologie der MedUni Wien.» EBMT: European Group for Blood and Marrow Transplantation Share WhatsappFacebookTwitterLinkedInXingMailBlueSky All News... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/in-german-meduni-wien-praesentiert-neue-mechanismen-fuer-transplantationen/
News ...Alle News Wissenschaftsfonds FWF fördert neue PhD-Doktoratskollegs der MedUni Wien (Wien, 05-12-2012) Wissenschaftsfonds FWF fördert neue PhD-Doktoratskollegs der MedUni Wien in den Bereichen Allergie- und Zellforschung. Wien wird dadurch als internationaler Standort für Allergieforschung weiter gestärkt. Der österreichische Wissenschaftsfonds FWF hat in der abschließenden Kuratoriumssitzung 2012 zwei Doktoratskollegs der MedUni Wien bewilligt. Gefördert werden das neue PhD-Doktoratskolleg „Molecular, Cellular and Clinical Allergology“ (MCCA, Koordinator Winfried F. Pickl, Institut für Immunologie, Zentrum für Patophysiologie, Infektiologie und Immunologie)“ sowie das bereits bestehende Doktoratskolleg „Cell Communication in Health and Desease“ (CCHD, Koordinator Stefan Böhm, Institut für Neurophysiologie und Neuropharmakologie, Zentrum für Physiologie und Pharmakologie... https://www.meduniwien.ac.at/web/ueber-uns/news/detail/20-neue-ausbildungsplaetze-fuer-top-forscherinnen/
COVID-19: not all patients develop protective antibodies ... COVID-19 do not always prevent virus receptor binding." Pia Gattinger, Kristina Borochova, Yulia Dorofeeva, Rainer Henning, Renata Kiss, Bernhard Kratzer, Bernhard Mühl, Thomas Perkmann, Doris Trapin, Martina Trella, Paul Ettel, Inna Tulaeva, Winfried F. Pickl, Rudolf Valenta. https://doi.org/10... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/2020/news-im-august-2020/covid-19-not-all-patients-develop-protective-antibodies/
Detailsite | MedUni Vienna ...All News The FWF Science Fund sponsors new PhD Doctoral Schools at the MedUni Vienna (Vienna, 5th December 2012) The FWF Science Fund sponsors new PhD Doctoral Schools at the MedUni Vienna in the fields of allergy and cell research, further boosting Vienna’s position as an international centre for allergy research. The Austrian FWF Science Fund has approved two Doctoral Schools for the MedUni Vienna at its final Board of Trustees Meeting. The sponsorship covers the new PhD Doctoral School entitled “Molecular, Cellular and Clinical Allergology” (MCCA, Coordinator Winfried F. Pickl, Institute of Immunology, Centre for) and the existing Doctoral School entitled “Cell Communication in Health and Disease” (CCHD, Coordinator Stefan Böhm, Institute of Neurophysiology and Neuropharmacology, Centre for Physiology and Pharmacology), creating 20 PhD training places.  “In... https://www.meduniwien.ac.at/web/en/about-us/news/detailsite/20-new-training-places-for-top-researchers/
"An Exciting Journey" - MCCA PhD Symposium and SFB F46 Closing Event | MedUni Vienna ...All Events An Exciting Journey Molecular, Cellular and Clinical Allergology (MCCA) PhD Symposium and SFB F46 'Towards prevention and therapy of allergy' Closing Event on Mechanisms of IgE-associated Diseases and Novel Approaches for the Therapy of Allergy and Beyond   Molecular, Cellular and Clinical Allergology (MCCA) is a doctoral program of the Medical University of Vienna and the Veterinary University of Vienna, Austria. SFB F46 'Towards prevention and therapy of allergy' is a special research program located at the Medical University of Vienna and the Karl-Franzens-University of Graz, Austria. Both programs are funded by the FWF Austrian Science Fund. Program 08:30 - 09:00 Registration 09:00 - 09:15 Opening Michaela Fritz, Vice Rector for Research and Innovation, Medical University of Vienna Winfried Pickl, MCCA Speaker Rudolf Valenta, SFB Speaker 09:15 - 10:10 Session One... https://www.meduniwien.ac.at/web/en/about-us/events/detail/an-exciting-journey-mcca-phd-symposium-and-sfb-f46-closing-event/
"An Exciting Journey" - MCCA PhD Symposium and SFB F46 Closing Event | MedUni Wien ...Alle Events An Exciting Journey Molecular, Cellular and Clinical Allergology (MCCA) PhD Symposium and SFB F46 'Towards prevention and therapy of allergy' Closing Event on Mechanisms of IgE-associated Diseases and Novel Approaches for the Therapy of Allergy and Beyond   Molecular, Cellular and Clinical Allergology (MCCA) is a doctoral program of the Medical University of Vienna and the Veterinary University of Vienna, Austria. SFB F46 'Towards prevention and therapy of allergy' is a special research program located at the Medical University of Vienna and the Karl-Franzens-University of Graz, Austria. Both programs are funded by the FWF Austrian Science Fund. Programm 08:30 - 09:00 Registration 09:00 - 09:15 Opening Michaela Fritz, Vice Rector for Research and Innovation, Medical University of Vienna Winfried Pickl, MCCA Speaker Rudolf Valenta, SFB Speaker 09:15 - 10:10 Session... https://www.meduniwien.ac.at/web/ueber-uns/events/detail/an-exciting-journey-mcca-phd-symposium-and-sfb-f46-closing-event/
Melanom: B-Lymphozyten sind entscheidend für erfolgreiche Immuntherapie ... Glatz, Heinz Läubli, Kirsten D. Mertz, Peter Petzelbauer, Thomas Wiesner, Markus Hartl, Winfried F. Pickl, Rajasekharan Somasundaram, Peter Steinberger, Stephan N. Wagner. DOI 10.1038/s41467-019-12160-2 Share Whatsapp Facebook LinkedIn Xing Mail BlueSky Alle News... https://www.meduniwien.ac.at/web/ueber-uns/news/detailseite/2019/news-im-september-2019/melanom-b-lymphozyten-sind-entscheidend-fuer-erfolgreiche-immuntherapie/medizin-wissenschaft/